Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioblastoma × Standard of Care × Clear all

Phase

Status

Withdrawn 2 Recruiting 2 Active not recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Colorectal Neoplasms 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Head and Neck Neoplasms 4 Lung Neoplasms 2 Liver Neoplasms 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Upper Excretory Tract Tumors 1 Ulcer 1 Thrombosis 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Disorders, Circadian Rhythm 1 Sezary Syndrome 1 Rectal Neoplasms 1 Radiodermatitis 1 Radiation Induced Oral Mucositis 1 Pulmonary Disease, Chronic Obstructive 1 Pulmonary Atelectasis 1 Protein Deficiency 1 Pneumonia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Motor Activity 1

Interventions

Temozolomide 40 Radiotherapy 15 Bevacizumab 9 Surgical Procedures, Operative 5 Carmustine 5 pembrolizumab 3 Sunitinib 3 Radiation 3 Procarbazine 3 Lomustine 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Chlorotoxin 3 Carboplatin 3 Blood Specimen Collection 3 fludarabine 2 camrelizumab 2 Radiosurgery 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Hyperbaric Oxygenation 2 Ethanol 2 Drug Therapy 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 CT-322 2 Bortezomib 2 Aminolevulinic Acid 2 verubulin 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05399524 2022-06-01

FUTURE-GB

University of Oxford

Phase NA Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡